1. Home
  2. VUZI vs ARCT Comparison

VUZI vs ARCT Comparison

Compare VUZI & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vuzix Corporation

VUZI

Vuzix Corporation

HOLD

Current Price

$2.76

Market Cap

221.1M

Sector

Technology

ML Signal

HOLD

Logo Arcturus Therapeutics Holdings Inc.

ARCT

Arcturus Therapeutics Holdings Inc.

HOLD

Current Price

$7.35

Market Cap

194.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VUZI
ARCT
Founded
1997
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
221.1M
194.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VUZI
ARCT
Price
$2.76
$7.35
Analyst Decision
Buy
Analyst Count
0
11
Target Price
N/A
$38.67
AVG Volume (30 Days)
1.6M
892.4K
Earning Date
11-13-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,310,001.00
$97,601,000.00
Revenue This Year
$5.53
N/A
Revenue Next Year
$110.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.47
$5.85
52 Week High
$5.79
$24.17

Technical Indicators

Market Signals
Indicator
VUZI
ARCT
Relative Strength Index (RSI) 49.60 41.80
Support Level $2.42 $7.04
Resistance Level $3.20 $7.76
Average True Range (ATR) 0.19 0.40
MACD 0.06 0.42
Stochastic Oscillator 55.50 75.21

Price Performance

Historical Comparison
VUZI
ARCT

About VUZI Vuzix Corporation

Vuzix Corp is engaged in the design, manufacture, and marketing of Artificial Intelligence (AI)-powered Smart Glasses, Waveguides, and Augmented Reality (AR) technologies. Its solutions serve the enterprise, medical, defense, security, and select consumer markets, offering cutting-edge wearable computing and display technologies that enhance productivity and operational efficiency. Its products include near-eye displays (NEDs), heads-up displays (HUDs), and wearable computing devices. Geographically, the company generates a majority of its revenue from the United States and also has a presence in Japan, the Netherlands, and other countries.

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

Share on Social Networks: